Merck Reports Insurance Concerns over Vioxx Litigation



DOCUMENTS
  • SEC Filing


WASHINGTON, D.C. - Merck & Co. Inc.'s current insurance coverage with respect to the Vioxx litigation may not be sufficient to cover its defense costs and any court losses over the withdrawn painkiller, according to the company's latest quarterly report filed with the SEC.

For the more than 14,200 Vioxx product liability lawsuits filed against Merck as of June 30, the company said it has insurance coverage with upper limits of approximately $630 million after deductibles and co-insurance.

The company added that it has not established any reserves for potential liability relating to the lawsuits or other investigations, including for …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

April 08, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's Data Breach Litigation Conference

March 26, 2025 - Charlotte, NC
Omni Charlotte Hotel

MORE DETAILS